Why the study?
Does Paf-acether reduce coronary flow and contractile force in isolated guinea-pig heart preparations?
Does Paf-acether reduce coronary flow and contractile force in isolated guinea-pig heart preparations?
Paf-acether exerts a potent, specific, concentration-dependent reduction in coronary flow and contractile force in isolated guinea-pig hearts.
Answers are grounded in this paper and cite their sources.
Paf-acether effects in isolated hearts warrant no clinical action; leaves open in vivo relevance or human translation.
Paf-acether (platelet-activating factor) is a phospholipid capable of stimulating platelets to release their granular contents and cause platelet aggregation. When Paf-acether was administered to isolated heart preparations from normal guinea-pigs there was a significant concentration-dependent reduction in coronary flow and contractile force. The high concentration of Paf-acether was equally effective in reducing these cardiac parameters in the presence of atropine. The non-acetylated Paf-acether analogue, 2-lyso Paf-acether, the enantiomer, and a closely related phospholipid 1, alpha-lysophosphatidylcholine palmitoyl, did not affect coronary flow and contractile force, indicating the specificity of Paf-acether. These data demonstrate a potent effect of Paf-acether on cardiac function. Whether or not these effects are direct or mediated through generation of endogenous mediators remains to be established.
No takes yet. Share an insight, caveat, or question.
Benveniste et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: